Design Therapeutics(DSGN)
CARLSBAD, CABiotechnology
Focus: Design Therapeutics is a public-stage biotech company focused on drugs targeting disorders caused by nucleotide-repeat expansions, operating across oncology, neurology, and infectious diseases. With 201-500 employees based in Carlsbad, CA, the company is advancing a diversified pipeline spanning multiple therapeutic modalities.
Profile data last refreshed Yesterday · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Employees
201-500
Open Jobs
0
About Design Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Design Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Early-stage
50 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$0K
Key Products
DT-216P2
Stable
Growth
Phase 1/2 program targeting a rare genetic disorder aligns with company's core nucleotide-repeat expansion thesis.
Help build intelligence for Design Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.